Sanoosa‑001
Chronic Inflammatory Disease
PreclinicalActive
Key Facts
About Sanoosa
Australian biotech developing oral small‑molecule drugs for inflammation, oncology and viral infections.
View full company profileChronic Inflammatory Disease
Australian biotech developing oral small‑molecule drugs for inflammation, oncology and viral infections.
View full company profile